Global Liquid Biopsy Products Market Growth (Status and Outlook) 2023-2029

Global Liquid Biopsy Products Market Growth (Status and Outlook) 2023-2029

Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.

This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.
LPI (LP Information)' newest research report, the “Liquid Biopsy Products Industry Forecast” looks at past sales and reviews total world Liquid Biopsy Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Liquid Biopsy Products sales for 2023 through 2029. With Liquid Biopsy Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liquid Biopsy Products industry.
This Insight Report provides a comprehensive analysis of the global Liquid Biopsy Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liquid Biopsy Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liquid Biopsy Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liquid Biopsy Products and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liquid Biopsy Products.
The global Liquid Biopsy Products market size is projected to grow from US$ 1676.7 million in 2022 to US$ 8668.9 million in 2029; it is expected to grow at a CAGR of 26.5% from 2023 to 2029.
The major players in global Liquid Biopsy Products market include RainDanceTechnologies, Biocartis, Qiagen, etc. The top 3 players occupy about 15% shares of the global market. North America is the main market. CTCs is the main type, with a share about 65%. Blood Sample is the main application, which holds a share about 90%.
This report presents a comprehensive overview, market shares, and growth opportunities of Liquid Biopsy Products market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
CTCs
ctDNA
Exosomes
Segmentation by application
Blood Sample
Urine Sample
Other Bio Fluids
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc

Please note: The report will take approximately 2 business days to prepare and deliver.